All Type of News
The ARB-type hypertension singular drug market has suffered from depression… Boryung is the only one grown
While the single drug market for domestic ARB-type hypertension treatments has been decreased, Boryung Pharm has kept its steady growth.
According to the Hana Daetoo Securities’s analysis result of the UBIST data, th...
Listed pharmaceutical companies were increased by 3.5% in stock prices
As stock prices of listed pharmaceutical companies have been increased by 3.5% in a month, they have received favorable comments of investors in the stock market.
According to the YakupDotCom’s analysis result of flu...
Master-level treatments?...the pharmaceutical industry is also concerning the first recruitment of 6-year college graduates of pharmacy
Although the pharmaceutical industry is desperate to recruit pharmacists in the R&D and clinical fields, college pharmacy graduates actually hesitate to apply for the pharmaceutical industry. Pharmaceutical companies ...
“I need to get you to hit the market”…two different contrasts in blockbuster-level pharmaceutical products last year
Last year, blockbuster-level pharmaceutical products had different score sheets in the outpatient market.
The recent data of outpatient prescription expenses by UBIST analyzed multinational pharmaceutical companies’ ...
Domestic and multinational companies focus on respective cardiovascular and anticancer treatments
Last year, domestic companies went for cardiovascular pharmaceutical products while multinational companies had focused on anticancer drugs.
According to the analysis result of the approval state of clinical trials i...
How much the pharmaceutical industry recognizeabout the Nagoya Protocol?
The Korea PharmaceuticalAssociation will conduct a survey to find recognition of the pharmaceutical industry towards the Nagoya Protocol reported 21 October 2014.
Since the key point of the Nagoya Protocol is for use...
Hepatitis type C treatments are expected to be the hot issue in the industry
Hepatitis type C treatments, attracting attention in the industry concerned, will become the hot issue in the second half of the year.
There is a higher chance the second generation hepatitis type B treatments will c...
“Let’s increase the chance to develop new drugs”…Hospitals tend to construct MOUs.
Again in this year, university hospitals have signed memorandums of understanding (MOU) with various institutions. Their goals are to increase chances of ‘new drugs’through using expertise of hospitals on the clinical...
Domestic pharmaceutical products have remained strong in the painkiller market… Geworin and Penzal have kept their momentum
Domestic pharmaceutical products, such as ‘Geworin’ and ‘Penzal’, remain strong in the recent painkiller market.
According to the recent IMS data, it is observed that the Johnson & Johnson’s Tylenol stayed the top on...
‘Hanmi’ will also enter the fluid cold medicine market… what are the objectives?Fluid cold medicines, syrup type cold medicines showed for the first time in 2009, were a concept for the young.
Fluid cold medicines have recently entered in the market by Cho...
|
